March 11, 2026

Could a hot cup of matcha dial down the ‘sneeze switch’ in allergic rhinitis?

by Hiroshima University edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Samet Burak Dağlıoğlu from Pexels There’s now another reason to love Japan’s famous matcha: A study in mice suggests that the green tea powder could reduce the need to sneeze in people with nasal allergies. Matcha is a […]

Could a hot cup of matcha dial down the ‘sneeze switch’ in allergic rhinitis? Read More »

Spinal stimulation above and below injury restores leg movement and sensory feedback in clinical trial

by Brown University edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source David Borton (left), an associate professor of engineering and brain science at Brown, and Jonathan Calvert (right), an assistant professor at UC Davis who led the research as a postdoctoral researcher at Brown. Credit: Nick Dentamaro / Brown University

Spinal stimulation above and below injury restores leg movement and sensory feedback in clinical trial Read More »

Long-read genome sequencing uncovers new autism gene variants –

by Miles Martin, University of California – San Diego edited by Robert Egan  Editors’ notes  The GIST Add as preferred source Graphical abstract. Credit: Cell Genomics (2026). DOI: 10.1016/j.xgen.2026.101186 Researchers at the University of California San Diego have identified new genetic variants associated with autism spectrum disorder (ASD) by using long-read whole genome sequencing (LR-WGS), an emerging approach that

Long-read genome sequencing uncovers new autism gene variants – Read More »

Blood marker for Alzheimer’s may also be useful in heart and kidney diseases

by German Center for Neurodegenerative Diseases edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: Pixabay/CC0 Public Domain A certain blood protein regarded as an early indicator of Alzheimer’s disease also appears to play a role in other disorders. Researchers at DZNE and the Hertie Institute for Clinical Brain Research

Blood marker for Alzheimer’s may also be useful in heart and kidney diseases Read More »

Giving Multiple Vaccines at Once Not Linked to Additional Risk for Reactions

PHILADELPHIA — Simultaneous administration of childhood vaccines against up to eight pathogens at one time did not result in any major adverse events or any greater side effects than a six-valent vaccine on its own, according to a poster presented at the annual meeting of the American Academy of Allergy, Asthma and Immunology 2026 Annual Meeting in

Giving Multiple Vaccines at Once Not Linked to Additional Risk for Reactions Read More »

Three-year study tracks early Parkinson’s decline using wearables and patient reports

by Critical Path Institute (C-Path) edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Credit: James Frid from Pexels A new study in the Journal of Neurology offers critical longitudinal insights into how symptoms and functional impacts evolve for individuals with early Parkinson’s disease (PD). Led by Jamie Adams, M.D. and Jennifer

Three-year study tracks early Parkinson’s decline using wearables and patient reports Read More »

What the ‘Relax Your Tight End’ Super Bowl Ad Got Wrong About PSA Screening –

Kenneth W. Lin, MD, MPH DISCLOSURESMarch 06, 2026 Hi, everyone. I’m Dr Kenny Lin. I am a family physician and associate director of the Lancaster General Hospital Family Medicine Residency, and I blog at Common Sense Family Doctor. The National Cancer Institute sponsors a “Know Your Chances” website that lets clinicians and patients create interactive charts showing the

What the ‘Relax Your Tight End’ Super Bowl Ad Got Wrong About PSA Screening – Read More »

China is going after the world’s most expensive drugs

Signal Tom Randall VP Endpoints News, Head of Signal Jared Whitlock Features Editor Gene therapies were supposed to be competition-proof. They are scientifically complex, require bespoke manufacturing, often go after small patient populations and can cost millions per dose. But that assumption is being tested by a wave of competitors being developed in China —

China is going after the world’s most expensive drugs Read More »

Scroll to Top